This excerpt taken from the EYE 8-K filed Feb 13, 2007.
In 2005, the company reported a GAAP net loss of $453.2 million, or a loss of $8.28 per share. After-tax charges of $536.9 million related primarily to acquisitions, recapitalizations and rationalization and repositioning actions had the effect of reducing per-share results by $9.73.
In 2006, we made progress toward our strategy to establish AMO as the refractive company, said Jim Mazzo, AMO chairman, president and chief executive officer. We grew our monofocal IOL, refractive IOL and phacoemulsification businesses. We expanded our LVC business and began to establish a procedure-based model overseas, while moving to strengthen our global LVC technology leadership with strategic acquisitions. We successfully repositioned our eye care business by streamlining our offering to focus on higher-margin products, while aggressively addressing the recall at the end of the year. In addition, we prepared to introduce a series of new products across each of our businesses in 2007.